Test Code

CP450

Ordering Code

3636

Questions?

Please call Clinical Labs of Hawaii at 808.677.7998 (Option 1) with questions about this test.

Synonyms

  • 16924 AccuType CP, Cytochrome P450 2C19, Plavix(R), Plavix variant CYP2C19

Remarks

CPT Code is subject to a Medicare Limited Coverage Policy and may require a signed ABN when ordering. This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by FDA. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.

Specimen Preparation

4 mL (2 mL minimum) Whole Blood EDTA (Lavender top)
tube preferred. ACD (Yellow top) or Sodium Heparin
(Dark Green top no gel) is acceptable.

Stability (from collection to initiation)

Room temperature: 8 days
Refrigerated: 30 days
Frozen: 49 days

Unacceptable Conditions

Serum; gel tubes.

Storage/Transport Temperature

Refrigerated

Reported

Performed: Tues, Fri; Reported: 4-8 days

Methodology

Polymerase Chain Reaction/Single Nucleotide Primer Extension

Test Site

Quest (16924)

Reference Interval

See report

CPT Codes

81225

LOINC

  • 57132-3

Specimen Preparation

4 mL (2 mL minimum) Whole Blood EDTA (Lavender top)
tube preferred. ACD (Yellow top) or Sodium Heparin
(Dark Green top no gel) is acceptable.

Storage/Transport Temperature

Refrigerated

Stability (from collection to initiation)

Room temperature: 8 days
Refrigerated: 30 days
Frozen: 49 days

Unacceptable Conditions

Serum; gel tubes.

LOINC

  • 57132-3

Synonyms

  • 16924 AccuType CP, Cytochrome P450 2C19, Plavix(R), Plavix variant CYP2C19

CPT Codes

81225

Test Code

CP450

Ordering Code

3636

Remarks

CPT Code is subject to a Medicare Limited Coverage Policy and may require a signed ABN when ordering. This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by FDA. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.

Reported

Performed: Tues, Fri; Reported: 4-8 days

Methodology

Polymerase Chain Reaction/Single Nucleotide Primer Extension

Reference Interval

See report

Test Site

Quest (16924)
Summary

Test Code

CP450

Ordering Code

3636

Questions?

Please call Clinical Labs of Hawaii at 808.677.7998 (Option 1) with questions about this test.

Synonyms

  • 16924 AccuType CP, Cytochrome P450 2C19, Plavix(R), Plavix variant CYP2C19

Remarks

CPT Code is subject to a Medicare Limited Coverage Policy and may require a signed ABN when ordering. This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by FDA. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.

Specimen Preparation

4 mL (2 mL minimum) Whole Blood EDTA (Lavender top)
tube preferred. ACD (Yellow top) or Sodium Heparin
(Dark Green top no gel) is acceptable.

Stability (from collection to initiation)

Room temperature: 8 days
Refrigerated: 30 days
Frozen: 49 days

Unacceptable Conditions

Serum; gel tubes.

Storage/Transport Temperature

Refrigerated

Reported

Performed: Tues, Fri; Reported: 4-8 days

Methodology

Polymerase Chain Reaction/Single Nucleotide Primer Extension

Test Site

Quest (16924)

Reference Interval

See report

CPT Codes

81225

LOINC

  • 57132-3
Collection

Specimen Preparation

4 mL (2 mL minimum) Whole Blood EDTA (Lavender top)
tube preferred. ACD (Yellow top) or Sodium Heparin
(Dark Green top no gel) is acceptable.

Storage/Transport Temperature

Refrigerated

Stability (from collection to initiation)

Room temperature: 8 days
Refrigerated: 30 days
Frozen: 49 days

Unacceptable Conditions

Serum; gel tubes.
Administrative

LOINC

  • 57132-3

Synonyms

  • 16924 AccuType CP, Cytochrome P450 2C19, Plavix(R), Plavix variant CYP2C19

CPT Codes

81225
Ordering

Test Code

CP450

Ordering Code

3636

Remarks

CPT Code is subject to a Medicare Limited Coverage Policy and may require a signed ABN when ordering. This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by FDA. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.
Result Interpretation

Reported

Performed: Tues, Fri; Reported: 4-8 days

Methodology

Polymerase Chain Reaction/Single Nucleotide Primer Extension

Reference Interval

See report

Test Site

Quest (16924)